U.S. Should Substantially Boost Support for Manufacturing USA Program, Issue National Industrial Manufacturing Strategy, Says New Report


To better compete globally, the United States should develop a comprehensive industrial strategy to align resources for manufacturing and maximize the national security and economic impacts of the Manufacturing USA program, a proven model that connects the key actors — small and large industry, engineering and science expertise, state and local government, and economic development stakeholders — needed to advance progress in manufacturing technology, says a new report by the National Academies of Sciences, Engineering, and Medicine. Nearly all leading competitor nations have detailed national manufacturing strategies that are aligned with their national economic strategies and view manufacturing as crucial to their growth and national security, the report says.

Strengthening the Manufacturing USA program — a public-private partnership coordinated through the National Institute of Standards and Technology comprising 17 institutes that specialize in different types of advanced manufacturing — is essential for bolstering U.S. competitiveness in the next decade, the report says. The network of institutes is a vital national asset that plays a central role in aligning innovation efforts across government, industry, and academia, connecting American businesses of all sizes with state-of-the-art technology and translating the latest breakthroughs into industrial practice.

However, the report says, the nation is missing a coordinated framework to align industry and government efforts, which has led to under-resourcing federal manufacturing programs, including Manufacturing USA, and a lack of investments to scale up production in proven areas.

As a result, U.S. manufacturing productivity — once a hallmark of the economy — has declined markedly in the past 15 years, the report says. China has been the world leader of manufacturing output since 2011, and currently holds around 35 percent of gross world manufacturing, compared to 12 percent in the U.S. The U.S. trade deficit in goods has also risen sharply, reaching a record $1.2 trillion in 2025, which includes a major deficit in advanced technologies such as aircraft, semiconductors, and robots.

“Even though the U.S. develops many manufacturing technologies, the nation continues to outsource most of its manufacturing and lags far behind other nations in production capacity,” said Theresa Kotanchek, chief executive officer of Evolved Analytics LLC and chair of the committee that wrote the report. “This presents risks to our supply chains, our economy, and our national security if we can’t access critical technologies when we need them most. Our report outlines actions to strengthen the Manufacturing USA program and U.S. advanced manufacturing so that we can grow the businesses and produce the technologies we need at home.”

The report calls on the National Economic Council, Office of Science and Technology Policy, the departments of Commerce, Defense, and Energy, and other agencies to develop within the next two years an industrial strategy — in concert with the National Security Strategy — that integrates technology development, scale-up financing, and leadership in standards, trade, and workforce development so that resources are aligned for a more robust U.S. advanced manufacturing posture.

Informed by tools available in leading advanced manufacturing countries, Congress and federal agencies should set policy to create new federal manufacturing and financing mechanisms that include long-term investment vehicles such as patient-capital funds, a sovereign wealth fund with a strategic focus on manufacturing, and intellectual-property backed lending financing. In addition, Congress should create a globally competitive research and development tax credit for manufacturing processes and technologies, as well as explore expanding other tax reforms that support manufacturing.

Congress should provide sustained, dedicated funding above current appropriations by 2030 to establish business development offices at each Manufacturing USA institute, the report says. These offices would support commercialization, scale-up, and regional ecosystem integration, particularly for entrepreneurs and small- and medium-sized manufacturers (SSMs) working in coordination with regional economic development organizations and federal manufacturing programs.

Technology transfer is central to the Manufacturing USA mission. Institutes need to support two small firm extremes, both of which often lack the capital and resources to scale up — at one end, small, innovative entrepreneurs with good ideas to develop nascent technologies and at the other, SSMs that need to implement proven technologies. Additionally, large, multinational corporations that are institute members want to accelerate technology transfer to reduce their risks in scaling up investments. The report recommends establishing dedicated in-house technology transfer teams to help bridge the innovation “valley of death” between early-stage research and full-scale production.

Supporting robust pathways to careers in advanced manufacturing is necessary to cultivate a skilled workforce that can operate, maintain, and improve complex emerging manufacturing technologies in areas such as robotics, data analysis, digital production, and new materials. Yet, attracting and retaining talent remains a challenge, the report says.

“Collaboration across institutions and work sectors, to align student outcomes with industry needs, is necessary for the U.S. to become a leader in advanced manufacturing,” said National Academy of Engineering President Tsu-Jae Liu. “This report highlights the importance of workforce development for achieving and maintaining a competitive edge in advanced manufacturing, for economic prosperity and national security. 

Manufacturing USA institutes should adopt a broad range of programs to address workforce education needs that are built around a unified advanced manufacturing curriculum, the report says. In collaboration with regional stakeholders, this should include broad support for manufacturing apprenticeships and the development of comprehensive online advanced manufacturing courses.

The report also calls for a new interagency council to enable cross-agency and cross-institute collaboration, reduce administrative barriers, develop a digital manufacturing strategy, and establish an integrated strategy for the manufacturing institutes. Cross-agency collaboration is important between institute sponsoring agencies as well as between the institutes and other federal programs, including the national laboratories and the Manufacturing Extension Partnership program, to ensure advanced manufacturing technologies developed by the institutes are disseminated widely. Federal funding on par with comparable effective programs abroad is critical for supporting these activities.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective analysis and advice to the nation to solve complex problems and inform public policy decisions related to science, engineering, and medicine. They operate under an 1863 congressional charter to the National Academy of Sciences, signed by President Lincoln.

For more information, visit https://www.nationalacademies.org/.

Free Training

Source link

Bluejay Diagnostics Partners with Argonaut Manufacturing Services to Enhance U.S. Manufacturing for Symphony™ Platform


ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”) (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing for critical care, today announced a strategic partnership with Argonaut Manufacturing Services (“Argonaut”) to support the advancement of Bluejay’s Symphony™ platform.

This partnership is designed to support Bluejay’s broader efforts to establish scalable U.S.-based manufacturing capabilities aligned with its ongoing clinical development programs and future commercialization objectives. In addition, the partnership is intended to strengthen Bluejay’s future commercial infrastructure by supporting broader product distribution across the United States, enhancing supply chain resilience, and reducing potential risks associated with international sourcing and import tariffs. The collaboration is also intended to mitigate risks associated with Bluejay’s current reliance on overseas manufacturing by establishing domestic manufacturing capabilities that can provide greater operational control, business continuity, and supply chain security. By leveraging U.S.-based manufacturing and distribution capabilities, Bluejay aims to improve operational flexibility, support future market demand, and further enhance its ability to commercialize innovative near-patient diagnostic solutions for critical care settings.

“We are pleased to partner with Argonaut as we continue to advance the Symphony™ platform,” said Neil Dey, President and Chief Executive Officer of Bluejay Diagnostics. “This collaboration reflects our commitment to building a scalable and quality-focused operational foundation as we progress toward key commercial milestones.”

“Argonaut is committed to partnering with innovative companies to support the advancement of differentiated diagnostic technologies,” said Rick Hancock, Chief Executive Officer of Argonaut Manufacturing Services. “We value this collaboration with Bluejay Diagnostics and look forward to supporting their efforts as they continue to develop solutions aimed at improving clinical decision-making in critical care settings.”


Note: Investigational device. Limited by United States law to investigational use.


About the SYMON Clinical Study Program:

The SYMON Clinical Study Program includes SYMON-I (clinicaltrials.gov ID NCT06181604), SYMON-II (NCT06654895), and SYMON-III (NCT07425587). SYMON-I is a pilot study to determine IL-6 levels associated with various endpoints, including, but not limited to 28-day all-cause mortality and in-hospital mortality. The SYMON-II study is the pivotal study to validate the outcomes of the SYMON-I study, which the Company plans to use to support a 510(k) application to the FDA. The SYMON-III study is a pilot study to determine IL-6 levels associated with patients presenting with increasing severity of infection in the emergency department and risk of developing sepsis.



About Bluejay Diagnostics:

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay does not yet have regulatory clearance for the Symphony System, and we will need to receive regulatory authorization from the U.S. Food and Drug Administration before Symphony can be marketed as a diagnostic product in the United States. Bluejay’s first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from ’sample-to-result’ to help medical professionals make earlier and better triage/treatment decisions. More information is available at www.bluejaydx.com.



About Argonaut Manufacturing Services:


Argonaut Manufacturing Services

is a contract manufacturing organization focused on supporting life sciences and diagnostics companies with high-quality manufacturing solutions. Founded by former executives from companies such as Thermo Fisher Scientific, Affymetrix, and Allergan, Argonaut was built to provide a better, customer-focused approach to contract manufacturing.

The company’s mission is centered on improving the human condition by helping partners bring innovative healthcare products to market efficiently and reliably. Drawing from decades of industry experience, Argonaut emphasizes quality, operational excellence, and strong customer collaboration to help clients achieve their commercial and development goals in the health and life sciences industries.


Forward-Looking Statements:

This press release contains statements that the Company believes are “forward-looking statements” within the meaning of the Private Litigation Reform Act. Forward-looking statements may be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “suggest,” “will,” and similar expressions. The Company has based these forward-looking statements on its current expectations and projections about future events, nevertheless, actual results or events could differ materially from the plans, intentions and expectations disclosed in, or implied by, the forward-looking statements the Company makes. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including market and other conditions and those discussed under item 1A. “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in Part II, Item 1A, “Risk Factors” in its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026. You should not place undue reliance on these forward-looking statements, as they are subject to risks and uncertainties, and actual results and performance in future periods may not occur or may be materially different from any future results or performance suggested by the forward-looking statements in this release. This press release speaks as of the date indicated above. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. The Company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any future changes in the Company’s expectations of results or any future change in events, except as required by law.


Investor Contact:


Neil Dey

Bluejay Diagnostics, Inc.


[email protected]



Website: www.bluejaydx.com

Free Training

Source link

US Dollar gains ground after strong Manufacturing data as US-Iran tensions persist


Here is what you need to know for Tuesday, June 2:

The US Dollar Index (DXY) rises toward the 99.20 region on Monday after stronger-than-expected US manufacturing data reinforced confidence in the resilience of the United States (US) economy.

The ISM Manufacturing PMI rose to 54 in May from 52.7, beating expectations of 53, while the Employment Index improved to 48.6. Meanwhile, investors continued monitoring developments in the Middle East after Iran halted message exchanges with the United States, although sentiment improved later after President Donald Trump stated that there would be no troops sent to Beirut and that Hezbollah had agreed to stop all shooting.

US Dollar Price Today

The table below shows the percentage change of US Dollar (USD) against listed major currencies today. US Dollar was the strongest against the New Zealand Dollar.

USDEURGBPJPYCADAUDNZDCHFUSD0.22%-0.06%0.27%0.28%0.29%0.88%0.71%EUR-0.22%-0.27%0.00%0.07%0.13%0.68%0.48%GBP0.06%0.27%0.30%0.34%0.32%0.90%0.74%JPY-0.27%0.00%-0.30%0.04%0.05%0.65%0.45%CAD-0.28%-0.07%-0.34%-0.04%0.00%0.59%0.41%AUD-0.29%-0.13%-0.32%-0.05%0.00%0.53%0.39%NZD-0.88%-0.68%-0.90%-0.65%-0.59%-0.53%-0.18%CHF-0.71%-0.48%-0.74%-0.45%-0.41%-0.39%0.18%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the US Dollar from the left column and move along the horizontal line to the Japanese Yen, the percentage change displayed in the box will represent USD (base)/JPY (quote).

EUR/USD stumbles near the 1.1630 area, pressured by broad US Dollar strength following the upbeat ISM report. The pair struggles to gain traction as markets focus on resilient US economic data.

GBP/USD trades muted near 1.3460 as the Greenback weakens after its early rally. The pair remains under pressure despite relatively stable risk sentiment.

USD/JPY advances toward the 159.70 zone as higher US yields and stronger US economic data support the pair. The pair is close to intervention levels, so investors will watch any Japanese reaction when the Asian session opens.

AUD/USD declines toward the 0.7160 region as the stronger US Dollar and cautious market sentiment weigh on the Australian Dollar (AUD).

West Texas Intermediate (WTI) Oil trades near $92.40 per barrel after volatile headlines surrounding the Middle East. Prices initially found support after Iran suspended message exchanges with the US, but gains were limited after Trump stated he was not worried about Oil prices even if Iran were to block the Strait of Hormuz and indicated that tensions in Lebanon may ease.

Gold (XAU/USD) fell near the $4,480 region, even amid geopolitical uncertainty, as markets choose to back the stronger US Dollar and rising Treasury yields following the upbeat ISM Manufacturing report.

What’s next in the docket:

Tuesday, June 2:

  • Eurozone CPI
  • US JOLTS Job Openings
  • NZ Building Permits
  • AU AiG Industry Index
  • AU PMI
  • AU Q1 GDP
  • China Caixin Services PMI

Wednesday, June 3:

  • Spain Services PMI
  • Germany PMI
  • Eurozone PMI
  • Eurozone PPI
  • US ADP Employment Change 4-week average
  • US PMI
  • US Factory Orders
  • AU Trade Balance

Thursday, June 4:

  • CH CPI
  • Eurozone Retail Sales
  • US Challenger Job Cuts
  • US Initial Jobless Claims
  • US Nonfarm Productivity
  • US Unit Labor Costs
  • JP Labor Cash Earnings

Friday, June 5:

  • Eurozone GDP
  • Eurozone Employment Change
  • CA Employment Report
  • CA Average Hourly Wages
  • CA Unemployment Rate
  • US Nonfarm Payrolls
  • US Unemployment Rate
  • US Average Hourly Earnings
  • US Labor Force Participation Rate
  • CA Ivey PMI

WTI Oil FAQs

WTI Oil is a type of Crude Oil sold on international markets. The WTI stands for West Texas Intermediate, one of three major types including Brent and Dubai Crude. WTI is also referred to as “light” and “sweet” because of its relatively low gravity and sulfur content respectively. It is considered a high quality Oil that is easily refined. It is sourced in the United States and distributed via the Cushing hub, which is considered “The Pipeline Crossroads of the World”. It is a benchmark for the Oil market and WTI price is frequently quoted in the media.

Like all assets, supply and demand are the key drivers of WTI Oil price. As such, global growth can be a driver of increased demand and vice versa for weak global growth. Political instability, wars, and sanctions can disrupt supply and impact prices. The decisions of OPEC, a group of major Oil-producing countries, is another key driver of price. The value of the US Dollar influences the price of WTI Crude Oil, since Oil is predominantly traded in US Dollars, thus a weaker US Dollar can make Oil more affordable and vice versa.

The weekly Oil inventory reports published by the American Petroleum Institute (API) and the Energy Information Agency (EIA) impact the price of WTI Oil. Changes in inventories reflect fluctuating supply and demand. If the data shows a drop in inventories it can indicate increased demand, pushing up Oil price. Higher inventories can reflect increased supply, pushing down prices. API’s report is published every Tuesday and EIA’s the day after. Their results are usually similar, falling within 1% of each other 75% of the time. The EIA data is considered more reliable, since it is a government agency.

OPEC (Organization of the Petroleum Exporting Countries) is a group of 12 Oil-producing nations who collectively decide production quotas for member countries at twice-yearly meetings. Their decisions often impact WTI Oil prices. When OPEC decides to lower quotas, it can tighten supply, pushing up Oil prices. When OPEC increases production, it has the opposite effect. OPEC+ refers to an expanded group that includes ten extra non-OPEC members, the most notable of which is Russia.

Free Training

Source link